Charles Schwab
PRAX icon

Charles Schwab’s Praxis Precision Medicines PRAX Stock Holding History

Charles Schwab’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.7M Buy
220,008
+4,561
+2% +$1.44M 0.01% 975
2026
Q1 		$69.4M Buy
215,447
+17,146
+9% +$5.3M 0.01% 936
2025
Q4 		$58.4M Buy
198,301
+36,640
+23% +$6.82M 0.01% 1053
2025
Q3 		$8.57M Buy
161,661
+9,217
+6% +$447K ﹤0.01% 2181
2025
Q2 		$6.41M Buy
152,444
+11,364
+8% +$433K ﹤0.01% 2225
2025
Q1 		$5.34M Sell
141,080
-1,812
-1% -$113K ﹤0.01% 2244
2024
Q4 		$11M Buy
142,892
+5,840
+4% +$423K ﹤0.01% 1970
2024
Q3 		$7.89M Buy
137,052
+89,578
+189% +$4.84M ﹤0.01% 2151
2024
Q2 		$1.96M Buy
47,474
+40,785
+610% +$1.93M ﹤0.01% 2703
2024
Q1 		$408K Buy
+6,689
New +$300K ﹤0.01% 3105
2023
Q4 		– Sell
-1,410
Closed -$36.2K – 3559
2023
Q3 		$36.2K Hold
1,410
– – ﹤0.01% 3438
2023
Q2 		$24.3K Sell
1,410
-7,210
-84% -$110K ﹤0.01% 3536
2023
Q1 		$105K Buy
8,620
+1,262
+17% +$53.3K ﹤0.01% 3244
2022
Q4 		$263K Buy
7,358
+1,746
+31% +$54.5K ﹤0.01% 3142
2022
Q3 		$192K Sell
5,612
-11,609
-67% -$578K ﹤0.01% 3169
2022
Q2 		$633K Buy
17,221
+276
+2% +$29.5K ﹤0.01% 2973
2022
Q1 		$2.6M Buy
16,945
+428
+3% +$87.9K ﹤0.01% 2555
2021
Q4 		$4.88M Buy
16,517
+656
+4% +$192K ﹤0.01% 2367
2021
Q3 		$4.4M Buy
15,861
+7,880
+99% +$2.14M ﹤0.01% 2433
2021
Q2 		$2.19M Buy
7,981
+3,138
+65% +$1.12M ﹤0.01% 2684
2021
Q1 		$2.38M Buy
4,843
+192
+4% +$137K ﹤0.01% 2612
2020
Q4 		$3.84M Buy
+4,651
New +$2.71M ﹤0.01% 2348

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Charles Schwab's PRAX Position: Q2 2026 in Review

Charles Schwab increased its Praxis Precision Medicines (PRAX) stake by 2.1% in Q2 2026, buying an estimated $1.44M and bringing the position to 220,008 shares worth $73.7M. The position accounts for 0.01% of the portfolio, ranked #975.

Charles Schwab first reported a position in PRAX in Q4 2020 and has held it in 22 quarters since. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Charles Schwab held 220,008 shares of Praxis Precision Medicines worth $73.7M as of Q2 2026.
  • Charles Schwab bought 4,561 Praxis Precision Medicines shares in Q2 2026, an estimated $1.44M.
  • Praxis Precision Medicines made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #975 holding.
  • Charles Schwab first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 22 quarters since.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.